This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Gi Cell, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Dong Woo Ko in Natural Killer Cell Culturing
Introduction
Dong Woo Ko is an accomplished inventor based in Seoul, South Korea. He has made significant contributions to the field of immunology, particularly in the culturing of natural killer (NK) cells. His innovative work focuses on enhancing the efficacy of NK cells for cancer treatment.
Latest Patents
Dong Woo Ko holds a patent for a composition designed for culturing natural killer cells. The patent, titled "Composition for culturing natural killer cells and method for preparing natural killer cells by using same," describes a fusion protein that combines IL-2 and CD80 proteins. This composition promotes the proliferation of NK cells, induces the expression of CD16 and NKp46, and enhances the secretion of granzyme B and perforin. As a result, it is effectively usable in preparing NK cells with superior anticancer immune functions.
Career Highlights
Dong Woo Ko is associated with Gi Cell, Inc., where he continues to advance research in cell therapy. His work has positioned him as a key figure in the development of innovative treatments for cancer, leveraging the power of the immune system.
Collaborations
He collaborates with notable colleagues, including Myoung Ho Jang and Chun-Pyo Hong, to further enhance the research and application of NK cell therapies.
Conclusion
Dong Woo Ko's contributions to the field of natural killer cell culturing represent a significant advancement in cancer immunotherapy. His innovative approaches and collaborative efforts continue to pave the way for new treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile